Featured Research

from universities, journals, and other organizations

Inhaled Steroids Best Treatment For Children With Asthma, Study Finds

Date:
January 24, 2007
Source:
NIH/National Heart, Lung, and Blood Institute
Summary:
Although several medications are available to help children maintain asthma control, clinical trials directly comparing them have not been conducted. In fact, current recommendations in national and international asthma guidelines are based either on studies of single treatments compared to a placebo in children or on comparison studies in adults.

Although several medications are available to help children maintain asthma control, clinical trials directly comparing them have not been conducted. In fact, current recommendations in national and international asthma guidelines are based either on studies of single treatments compared to a placebo in children or on comparison studies in adults.

For the first time, researchers compared the effectiveness and safety of three different asthma medicines for initial daily therapy for school-aged children with mild to moderate persistent asthma: a low dose inhaled corticosteroid (200 mcg fluticasone a day); a combination of a lower dose inhaled corticosteroid and an inhaled long acting beta2 agonist (100 mcg fluticasone each morning plus 50mcg salmeterol twice daily), and a leukotriene receptor antagonist (montelukast).

Studying 285 children ages 6 -- 14 years, researchers in the Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute (NHLBI) found that after 48 weeks, inhaled corticosteroids are the most effective initial daily therapy for children with mild to moderate persistent asthma. They also found no significant adverse growth effects among any of the medicines studied.

"Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial," is published in this month's issue of the Journal of Allergy and Clinical Immunology (JACI). These results support the current asthma clinical guidelines, which recommend inhaled corticosteroids as the preferred initial therapy for children with mild to moderate asthma.

The theme of the January issue of the journal is National Institutes of Health asthma networks. The issue features review articles on several NHLBI programs -- the Asthma Clinical Research Network, the Childhood Asthma Research and Education Network, the Childhood Asthma Management Program, and the Severe Asthma Research Program -- as well as the Asthma and Allergic Diseases Research Centers and the Inner City Asthma Consortium of the National Institute of Allergy and Infectious Diseases (NIAID).


Story Source:

The above story is based on materials provided by NIH/National Heart, Lung, and Blood Institute. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Heart, Lung, and Blood Institute. "Inhaled Steroids Best Treatment For Children With Asthma, Study Finds." ScienceDaily. ScienceDaily, 24 January 2007. <www.sciencedaily.com/releases/2007/01/070123143233.htm>.
NIH/National Heart, Lung, and Blood Institute. (2007, January 24). Inhaled Steroids Best Treatment For Children With Asthma, Study Finds. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2007/01/070123143233.htm
NIH/National Heart, Lung, and Blood Institute. "Inhaled Steroids Best Treatment For Children With Asthma, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2007/01/070123143233.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins